01 1Wavelength Pharmaceuticals
01 1CLASCOTERONE
01 1Israel
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-26
Pay. Date : 2024-05-20
DMF Number : 39935
Submission : 2024-06-06
Status : Active
Type : II
20
Wavelength Enterprises Ltd, based in Israel, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is CLASCOTERONE, with a corresponding US DMF Number 39935.
Remarkably, this DMF maintains an Active status since its submission on June 06, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 26, 2024, and payment made on May 20, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
